Department of Hepatobiliary and Pancreatic Surgery
Sichuan Cancer Hospital, Chengdu
肝胆胰外科 · Hepatobiliary and Pancreatic Surgery
This department treats conditions affecting the liver, bile ducts, and pancreas. For liver tumors, including primary and metastatic cancer, it performs various resections and offers infusion chemotherapy or embolization to shrink inoperable tumors for potential later surgery. Bile duct services include gallbladder removal, stone extraction, and radical resection for bile duct or gallbladder cancer. For pancreatic head cancer, the team assesses resectability and performs standard or extended radical surgeries, sometimes involving partial vein removal. For inoperable cases, it provides regional arterial infusion chemotherapy combined with immunomodulation. The department describes its comprehensive treatment for preventing liver cancer recurrence and two-step resection for inoperable pancreatic cancer as specialized techniques.
What the department treats
- Liver resection for primary and metastatic liver cancer
- Infusion chemotherapy and embolization for inoperable liver tumors
- Laparoscopic and open cholecystectomy
- Surgical treatment for bile duct and gallbladder stones
- Radical resection for bile duct and gallbladder cancer
- Regional arterial infusion chemotherapy for pancreatic head cancer
Key facts
- The department reports that its new surgical approach for pancreatic head cancer has increased the surgical resection rate to over 30%.
- The reported 5-year survival rate for pancreatic head cancer surgery is over 10%.
- Research on regional arterial infusion chemotherapy for unresectable pancreatic head cancer received the Third Prize of Sichuan Provincial Science and Technology Progress Award in 2001.
As described by the hospital.
Team
9 doctors listed, including 1 chief physicians. Its chief physicians have 1 first- or senior-author papers on PubMed since 2016.
| Chief physician | Clinical focus | Key papers since 2016 |
|---|---|---|
| Dr. Mingyi Zhang 张明仪 | Laparoscopic and open surgery, intraoperative radiotherapy, interventional therapy, ablation, targeted therapy, and immunotherapy for hepatobiliary and pancreatic tumors. | 1 |
Associate chief physicians
- Prof. Zhengwei Leng冷政伟
We are an independent coordination service, not part of this hospital. Team data comes from public doctor-listing platforms; publication counts come from PubMed, matched by full name and affiliation, and doctors with very common names are checked by hand before their papers are shown. How we build this directory.
Not sure which specialist is right?
Send your records. We find a specialist in the right field to review your case and write a treatment plan with a cost estimate.
Get a specialist opinion